ロード中...
Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is considered one of the deadliest tumors worldwide. The diagnosis is often possible only in the latter stages of the disease, with patients already presenting an advanced or metastatic tumor. It is also one of the cancers with poorest prognosis, presenting a...
保存先:
| 出版年: | Pharmaceuticals (Basel) |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8003696/ https://ncbi.nlm.nih.gov/pubmed/33804613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14030280 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|